NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,162,544 | +7.4% | 21,231 | +6.4% | 1.28% | +5.5% |
| Q2 2023 | $2,014,320 | +11.8% | 19,962 | +2.0% | 1.22% | +7.8% |
| Q1 2023 | $1,800,917 | +3.9% | 19,575 | +2.4% | 1.13% | -0.9% |
| Q4 2022 | $1,733,392 | +21.2% | 19,107 | +1.5% | 1.14% | +7.7% |
| Q3 2022 | $1,430,000 | -7.4% | 18,816 | +3.0% | 1.06% | -1.6% |
| Q2 2022 | $1,544,000 | +0.8% | 18,268 | +4.6% | 1.07% | +10.2% |
| Q1 2022 | $1,532,000 | +6.1% | 17,463 | +5.8% | 0.98% | +5.4% |
| Q4 2021 | $1,444,000 | +10.6% | 16,507 | +3.4% | 0.92% | -1.7% |
| Q3 2021 | $1,306,000 | -9.3% | 15,965 | +1.1% | 0.94% | -8.6% |
| Q2 2021 | $1,440,000 | +8.7% | 15,787 | +1.8% | 1.03% | +0.2% |
| Q1 2021 | $1,325,000 | -7.2% | 15,502 | +2.5% | 1.03% | -14.5% |
| Q4 2020 | $1,428,000 | – | 15,120 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |